Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
10.3389/fonc.2020.00763
Saved in:
Main Authors: | Sundar, R., Smyth, E.C., Peng, S., Yeong, J.P.S., Tan, P. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/196150 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
by: Sundar, R, et al.
Published: (2019) -
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
by: Leary, A, et al.
Published: (2021) -
QUANTITATIVE PROTEOMIC ANALYSIS OF HUMAN GASTRIC FLUID FOR BIOMARKER DISCOVERY
by: KAM SIOK YUEN
Published: (2018) -
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
by: Sundar, Raghav, et al.
Published: (2022) -
IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION
by: TAY CHIN KANG JOHAN
Published: (2019)